HomeCompareCOGZF vs PLD

COGZF vs PLD: Dividend Comparison 2026

COGZF yields 0.87% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.89M in total portfolio value
10 years
COGZF
COGZF
● Live price
0.87%
Share price
$1.50
Annual div
$0.01
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.9K
Annual income
$91.72
Full COGZF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — COGZF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCOGZFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, COGZF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
COGZF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

COGZF
Annual income on $10K today (after 15% tax)
$73.70/yr
After 10yr DRIP, annual income (after tax)
$77.96/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $4,038,038.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of COGZF + PLD for your $10,000?

COGZF: 50%PLD: 50%
100% PLD50/50100% COGZF
Portfolio after 10yr
$2.96M
Annual income
$2,375,408.45/yr
Blended yield
80.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

COGZF
No analyst data
Altman Z
12.8
Piotroski
8/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

COGZF buys
0
PLD buys
0
No recent congressional trades found for COGZF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCOGZFPLD
Forward yield0.87%3.10%
Annual dividend / share$0.01$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$20.9K$5.91M
Annual income after 10y$91.72$4,750,725.19
Total dividends collected$894.00$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: COGZF vs PLD ($10,000, DRIP)

YearCOGZF PortfolioCOGZF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,787$86.70$11,241$540.96$454.00PLD
2$11,629$87.40$13,019$991.13$1.4KPLD
3$12,531$88.07$15,801$1,870.97$3.3KPLD
4$13,497$88.69$20,609$3,701.21$7.1KPLD
5$14,531$89.28$29,919$7,867.97$15.4KPLD
6$15,638$89.83$50,631$18,617.74$35.0KPLD
7$16,823$90.35$105,528$51,352.20$88.7KPLD
8$18,092$90.83$287,364$174,449.42$269.3KPLD
9$19,449$91.29$1,081,760$774,280.77$1.06MPLD
10$20,903$91.72$5,908,209$4,750,725.19$5.89MPLD

COGZF vs PLD: Complete Analysis 2026

COGZFStock

Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.

Full COGZF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this COGZF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

COGZF vs SCHDCOGZF vs JEPICOGZF vs OCOGZF vs KOCOGZF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.